Scouting, Investing in and Nurturing Healthcare Innovation
EPOK Therapeutics announced today the completion of a $9.0m Seed Round financing
23 March 2023
EPOK Therapeutics Inc. (“EPOK” or the “Company”), a preclinical stage biotech company developing diabodies and antibody conjugates, announced today the completion of a $9.0m Seed Round financing, led by Canadian and Italian angel investors. The proceeds from the financing will support the preclinical development of two proprietary drug candidates. In conjunction with the financing, the […]Read more
DYVERTO AG GETS A COMBINED “SEED” FUNDING OF NEARLY 1 MILLION EUROS for the development of a novel treatment for small abdominal aortic aneurysms.
24 August 2022
Dyverto AG, an innovative start-up operating in the vascular sector created by CVLab, announces the entry into the share capital of Davide Bianchi and Nocturnal Labs SpA. The “seed” investment is intended for the development of a device aimed at stopping and potentially reversing the progression of arterial aneurysms. The funds will be used to […]Read more